Bioavailability of resveratrol
Author:
Top Cited Papers
- 24 January 2011
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1215 (1) , 9-15
Abstract
This paper reviews our current understanding of the absorption, bioavailability, and metabolism of resveratrol, with an emphasis on humans. The oral absorption of resveratrol in humans is about 75% and is thought to occur mainly by transepithelial diffusion. Extensive metabolism in the intestine and liver results in an oral bioavailability considerably less than 1%. Dose escalation and repeated dose administration of resveratrol does not appear to alter this significantly. Metabolic studies, both in plasma and in urine, have revealed major metabolites to be glucuronides and sulfates of resveratrol. However, reduced dihydroresveratrol conjugates, in addition to highly polar unknown products, may account for as much as 50% of an oral resveratrol dose. Although major sites of metabolism include the intestine and liver (as expected), colonic bacterial metabolism may be more important than previously thought. Deconjugation enzymes such as β‐glucuronidase and sulfatase, as well as specific tissue accumulation of resveratrol, may enhance resveratrol efficacy at target sites. Resveratrol analogs, such as methylated derivatives with improved bioavailability, may be important in future research.Keywords
This publication has 39 references indexed in Scilit:
- Selective Synthesis and Biological Evaluation of Sulfate-Conjugated Resveratrol MetabolitesJournal of Medicinal Chemistry, 2010
- Bacterial transformation of dietary lignans in gnotobiotic ratsFEMS Microbiology Ecology, 2010
- Quantification of trans-resveratrol and its metabolites in rat plasma and tissues by HPLCJournal of Pharmaceutical and Biomedical Analysis, 2010
- Interaction of dietary resveratrol with animal-associated bacteriaFEMS Microbiology Letters, 2009
- Determination of pterostilbene in rat plasma by a simple HPLC‐UV method and its application in pre‐clinical pharmacokinetic studyBiomedical Chromatography, 2009
- A rapid HPLC method for the quantification of 3,5,4′-trimethoxy-trans-stilbene (TMS) in rat plasma and its application in pharmacokinetic studyJournal of Pharmaceutical and Biomedical Analysis, 2009
- Therapeutic potential of resveratrol: the in vivo evidenceNature Reviews Drug Discovery, 2006
- BENZO[A]PYRENE-INDUCED ORAL CARCINOGENESIS AND CHEMOPREVENTION: STUDIES IN BIOENGINEERED HUMAN TISSUEDrug Metabolism and Disposition, 2006
- Sulfation of resveratrol in human liver: Evidence of a major role for the sulfotransferases SULT1A1 and SULT1E1Xenobiotica, 2005
- Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cellsBiochemical and Biophysical Research Communications, 1991